Skip to main content

Smart Pills Market Set to Soar Past USD 12.39 billion by 2030

The global Smart Pills market size is expected to reach USD 12.39 billion by 2030 and exhibit a CAGR of 12.8% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of chronic diseases, the need for non-invasive diagnostic and monitoring tools, advancements in microfabrication and wireless communication technologies, the rising aging population, and the demand for real-time health tracking and remote patient monitoring are fueling the market’s growth.

Westford, USA, Jan. 30, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Smart Pills market, the increasing use of ingestible sensors for real-time patient monitoring, the development of multi-functional smart pills capable of diagnostic and therapeutic functions, the integration of smartphone apps and wearable devices for data collection and analysis, the expansion of applications beyond traditional drug delivery to include health tracking and disease management, are the trends that aid in the market’s growth.

Browse in-depth TOC on “Smart Pills Market”

  • Pages – 157
  • Tables – 92
  • Figures – 76

Smart pills are ingestible electronic devices that can monitor physiological data, deliver drugs, or perform other functions inside the body. They are typically small, capsule-shaped devices that are swallowed and travel through the digestive system. Smart pills can contain a variety of sensors, including cameras, microphones, temperature sensors, and pH sensors.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/smart-pills-market

Prominent Players in Smart Pills Market

  • Proteus Digital Health
  • EtectRx
  • Lumeon
  • CapsoVision
  • Given Imaging
  • Orasis Pharmaceuticals
  • Intellijoint Surgical
  • Evoke Pharma
  • Rani Therapeutics
  • Medtronic
  • PillCam
  • Abilify MyCite
  • Pear Therapeutics
  • Akili Interactive
  • Huma
  • Click Therapeutics
  • Ginger
  • Happify Health
  • Talkspace
  • Headspace
  • Calm
  • Meditopia

Wireless Capsule Endoscopy Demand to Grow Substantially in the Forecast Period

Wireless Capsule Endoscopy dominate the global online market as it is minimally invasive and non-intrusive, making it more acceptable to patients compared to traditional endoscopy methods. This non-invasive approach leads to higher patient compliance and acceptance.

Monitoring Applications is the Leading Application Segment

In terms of application, the Monitoring applications is the leading segment as they are crucial for the management of chronic diseases, such as gastrointestinal disorders, diabetes, cardiovascular diseases, and neurological conditions. Continuous tracking of vital parameters and disease progression is essential for effective management.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/smart-pills-market

North America is the leading Market Due to the Technological Advancements

Region-wise, North America is one of the largest growing markets with a huge emphasis on technological advancements. The region has a high level of healthcare expenditure, enabling investment in cutting-edge medical technologies and encouraging healthcare facilities to adopt smart pills for diagnostics and monitoring.

A recent report thoroughly analyzes the major players operating within the Smart Pills market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavors to develop innovative solutions that cater to the ever-increasing demand for Smart Pills.

Key Developments in the Smart Pills Market

  • Proteus Digital Health announced that it had received FDA approval for its ingestible sensor system, which can be used to track medication adherence and provide real-time data to healthcare providers.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/smart-pills-market

Key Questions Answered in Smart Pills Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • Can you list the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Allergic Rhinitis Market

Global Coagulation Testing Market

Global Bleeding Disorders Treatment Market

Global Orthopedic Prosthetics Market

U.S. Speech Therapy Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.